| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
CNRS-UPR 0415 and Université Paris VII, Institut Cochin de Génétique Moléculaire, F-75014 Paris, France
Address all correspondence and requests for reprints to: Dr. Ralf Jockers, Laboratoire dImmuno-Pharmacologie Moléculaire, Institut Cochin de Génétique Moléculaire, 22 rue Méchain, F-75014 Paris, France. E-mail: jockers{at}icgm.cochin.inserm.fr
Activation of adenylyl cyclase by ß-adrenergic receptors (ßARs)
plays a major role in adipose tissue homeostasis. The increase in cAMP
promotes lipolysis in white adipose tissue, activates both
thermogenesis and lipolysis in brown adipose tissue (BAT), and induces
BAT hypertrophy. Previous studies indicated that among the three ßAR
subtypes present in adipose tissue, ß3AR could be a
potential target for antiobesity treatments in humans. We studied
immortalized human brown adipocytes (PAZ6 adipocytes) as a model of
ß-adrenergic response in human BAT. PAZ6 adipocytes and freshly
isolated mature human brown adipocytes display the same proportions of
ßAR subtypes, with ß3AR being the most abundant
(
80% of the total). However, ß3AR was poorly coupled
to the adenylyl cyclase pathway in PAZ6 cells, contributing to only
10% of the isoproterenol-induced accumulation of cAMP, whereas 20%
and 70% of the signal depended on ß1- and
ß2-subtypes, respectively. Upon isoproterenol
stimulation, ß1- and ß2AR down-regulated
with a half-life of about 3 h and the ß3AR with a
half-life of 3040 h. Long term stimulation with both saturating
(micromolar) and nonsaturating (nanomolar) concentrations of
ß-adrenergic agonists caused a complete desensitization of the
ß-adrenergic response at the adenylyl cyclase level and loss of
stimulated protein kinase A activity and CREB phosphorylation. These
results suggest that cAMP-dependent processes will be desensitized upon
permanent treatment with ß3AR agonists. Further studies
should establish whether the ß3AR is coupled to other
signaling pathways in human brown adipocytes and whether these may
contribute to BAT hypertrophy and/or thermogenesis.
This article has been cited by other articles:
![]() |
J.-L. Guillaume, A. M. Daulat, P. Maurice, A. Levoye, M. Migaud, L. Brydon, B. Malpaux, C. Borg-Capra, and R. Jockers The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor J. Biol. Chem., June 13, 2008; 283(24): 16762 - 16771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Breit, M. Lagace, and M. Bouvier Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Couturier and R. Jockers Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers J. Biol. Chem., July 11, 2003; 278(29): 26604 - 26611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brydon, L. Petit, P. Delagrange, A. D. Strosberg, and R. Jockers Functional Expression of MT2 (Mel1b) Melatonin Receptors in Human PAZ6 Adipocytes Endocrinology, October 1, 2001; 142(10): 4264 - 4271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, M. Xia Shi, T. D. Mitchell, G. N. Smagin, S. R. Thomas, D. H. Ryan, and R. B.S. Harris Changes in Rat Adipocyte and Liver Glucose Metabolism Following Repeated Restraint Stress Experimental Biology and Medicine, April 1, 2001; 226(4): 312 - 319. [Abstract] [Full Text] |
||||
![]() |
P. Penfornis, S. Viengchareun, D. Le Menuet, F. Cluzeaud, M.-C. Zennaro, and M. Lombes The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E386 - E394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Konkar, S. S. Vansal, G. Shams, P. F. Fraundorfer, W.-P. Zheng, V. I. Nikulin, J. D. L. Angeles, R. H. Fertel, D. D. Miller, and D. R. Feller beta -Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human beta -Adrenoceptors Expressed in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 875 - 883. [Abstract] [Full Text] |
||||
![]() |
C. C. Gerhardt, J. Gros, A. D. Strosberg, and T. Issad Stimulation of the Extracellular Signal-Regulated Kinase 1/2 Pathway by Human Beta-3 Adrenergic Receptor: New Pharmacological Profile and Mechanism of Activation Mol. Pharmacol., February 1, 1999; 55(2): 255 - 262. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |